The results indicate that baseline chemerin quantities were not predictive for weight loss-associated dynamics of body fat percentage (Figure 5A) and liver fibrosis—as was displayed by the NAFLD fibrosis score and FIB4 (Figure 5B,C)—in LCD patients within 12 months. The gene discussed is RARRES2; the disease is lattice corneal dystrophy type I.